Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett esophagus after antireflux surgery: late results

T Bright, DI Watson, W Tam, PA Game, D Astill… - 2007 - journals.lww.com
Objective: To determine the efficacy of endoscopic argon plasma coagulation (APC) for
ablation of Barrett esophagus. Summary Background Data: APC has been used to ablate …

Barrett's oesophagus: long‐term follow‐up after complete ablation with argon plasma coagulation and the factors that determine its recurrence

R Ferraris, M Fracchia, M Foti, L Sidoli… - Alimentary …, 2007 - Wiley Online Library
Background Argon plasma coagulation seems to be a promising technique for ablation of
Barrett's oesophagus, yet few long‐term efficacy data are available. Aim To report on a long …

Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing …

K Ragunath, N Krasner, V Sankara Raman… - Scandinavian journal …, 2005 - Taylor & Francis
Objective Endoscopic mucosal ablation is a promising technique that is used to treat
dysplastic Barrett's oesophagus. The purpose of this study was to investigate the efficacy …

Successful treatment of refractory Barrett's neoplasia with hybrid argon plasma coagulation: a case series

AJ Trindade, D Wee, P Wander, M Stewart, C Lee… - …, 2020 - thieme-connect.com
A 60-year-old woman with Barrett's esophagus (Prague class C8M10) with flat high grade
dysplasia underwent radiofrequency ablation (RFA) therapy. She underwent four sessions …

Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett's …

MF Peerally, P Bhandari, K Ragunath, H Barr… - Gastrointestinal …, 2019 - Elsevier
Background and Aims Endoscopic resection (ER) is safe and effective for Barrett's
esophagus (BE) containing high-grade dysplasia (HGD) or mucosal adenocarcinoma (T1A) …

Tu1161 safety and efficacy of endoscopic hybridapc for management of Barrett's esophagus

HMS Arshad, N Ahsan, T Aldridge… - Gastrointestinal …, 2017 - giejournal.org
Objectives Primary: To test the efficacy and safety of HybridAPC as a primary modality for
ablation of Barrett's esophagus. Secondary: To test the efficacy of HybridAPC in patients with …

Efficacy and safety of Hybrid-APC for the ablation of Barrett's esophagus

H Manner, A May, I Kouti, O Pech, M Vieth, C Ell - Surgical endoscopy, 2016 - Springer
Background and study aim After thermal ablation of Barrett's esophagus (BE), stricture
formation is reported in 5 to over 10% of patients. The question arises whether submucosal …

Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole

H Schulz, S Miehlke, D Antos, KU Schentke… - Gastrointestinal …, 2000 - Elsevier
Background: Barrett's esophagus is a premalignant condition induced by gastroesophageal
reflux. The aim of this prospective study was to assess the efficacy of argon plasma …

Treatment of Barrett's esophagus with argon plasma coagulation and antireflux surgery. A retrospective analysis.

A Formentini, A Schwarz, J Straeter… - Hepato …, 2007 - europepmc.org
Results BE ablation was obtained in all patients after a mean of 3.6 APC sessions. There
was no mortality and morbidity was 19%(4/21 patients). All patients underwent 360 degrees …

Randomized trials in the treatment of Barrett's esophagus

EM Faybush, RE Sampliner - Diseases of the Esophagus, 2005 - academic.oup.com
Treatment for Barrett's esophagus (BE) has consisted of medical treatment (acid
suppression medications), surgery (fundoplication) and endoscopic ablative techniques …